approval · primary record
CYCLOSPORINE
FDA · NDA · 2025-08-21
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-08-21 |
| Brand | RESTASIS MULTIDOSE |
| Sponsor | ABBVIE |
| Route | OPHTHALMIC |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:32.063Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:CYCLOSPORINE:2025-08-21
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.